EDGEMOND JAMES

PrivateCIK: 1636178
Location

SILVER SPRING, MD

EDGEMOND JAMES (CFO AND TREASURER) sold 34.6% of their position (10K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $5.48M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 8 sales
InsiderEDGEMOND JAMESCIK 1636178
IssuerUNITED THERAPEUTICS CORPCIK 1082554
Officer· CFO AND TREASURER
Since Mar 2023
-10K
Net shares
Net seller
$5.48M
Total sold
8
Open market trades
0B · 8S
10
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions9

Common Stock

Direct
M · Option Exercise

Shares

+10K

Price / share

$117.76

Trade value

$1.18M

% of position

53.0%
6/8/2026
18.88K28.88K

Common Stock

Direct
S · Sale

Shares

1.56K

Price / share

$544.93

Trade value

$852.82K

% of position

5.4%
6/8/2026
28.88K27.31K

Common Stock

Direct
S · Sale

Shares

1.99K

Price / share

$546.13

Trade value

$1.09M

% of position

7.3%
6/8/2026
27.31K25.32K

Common Stock

Direct
S · Sale

Shares

1.89K

Price / share

$547.03

Trade value

$1.03M

% of position

7.5%
6/8/2026
25.32K23.43K

Common Stock

Direct
S · Sale

Shares

2.16K

Price / share

$547.91

Trade value

$1.18M

% of position

9.2%
6/8/2026
23.43K21.28K

Common Stock

Direct
S · Sale

Shares

425.00

Price / share

$549.38

Trade value

$233.49K

% of position

2.0%
6/8/2026
21.28K20.85K

Common Stock

Direct
S · Sale

Shares

1.28K

Price / share

$550.09

Trade value

$706.87K

% of position

6.2%
6/8/2026
20.85K19.57K

Common Stock

Direct
S · Sale

Shares

610.00

Price / share

$551.28

Trade value

$336.28K

% of position

3.1%
6/8/2026
19.57K18.96K

Common Stock

Direct
S · Sale

Shares

80.00

Price / share

$551.75

Trade value

$44.14K

% of position

0.4%
6/8/2026
18.96K18.88K
Total

Net shares

+0.00

Net value

-$4.30M

Derivative Transactions1

Stock Option

Direct
M · Option Exercise
Converts to

Common Stock

10K shares

Shares

10K

Strike price

117.76

Held after

20K

Exercisable

6/8/2026
EDGEMOND JAMES — Insider Transaction (Form 4) Filed Jun 9, 2026 | Finecho